Navigation Links
Controversial Study to Test Link Between Insomnia and Sleep Apnea

Measuring Prevalence of Sleep Apnea Among Insomnia Patients

ALBUQUERQUE, N.M., Feb. 9 /PRNewswire/ -- The Sleep and Human Health Institute (SHHI) was awarded a grant to study one of the most controversial aspects of Chronic Insomnia. Conventional wisdom connects insomnia to psychological factors -- stress, racing thoughts, and worries -- and is usually treated with sleeping pills or talk therapy. Pitted against the CW is the provocative theory that a large percentage of Chronic Insomniacs suffer from Obstructive Sleep Apnea (OSA), a physical breathing problem that might cause unwanted or unexpected sleeplessness.

Several leading sleep researchers have espoused this theory for the last decade; and Philips Respironics, a world leader in the treatment of obstructive sleep apnea, has awarded a $50,000 grant to co-sponsor the study in Albuquerque, NM to measure the occurrence of OSA in Chronic Insomnia patients.

"The Sleep and Human Health Institute has a history of groundbreaking work, and this study will be an important advancement in understanding the relationship between Insomnia and Sleep Apnea," said David P. White, M.D., Chief Medical Officer, Philips Respironics. "We know there are many skeptics who insist Chronic Insomnia is largely a psychological problem, but recent studies on certain patients have already shown that continuous positive airway pressure (CPAP) therapy or upper airway surgery significantly decreases insomnia."

Unlike other studies that investigated patients at sleep centers, the new research will examine randomly selected patients seeking care at their primary care clinics. This approach provides data much closer to what goes on in the general population compared to sleep center cohorts.

"This opportunity will clarify whether Sleep Apnea is a common problem often overlooked in Chronic Insomnia patients," declared Dr. Barry Krakow, principal investigator and medical director of the Sleep & Human Health Institute. "We'll be using the latest respiratory technology to more accurately measure breathing, and we hypothesize that more than half of these Chronic Insomnia patients will suffer from previously undiagnosed Sleep Apnea." Dr. Krakow is also medical director of Maimonides Sleep Arts and Sciences, a co-sponsor of the research.

SOURCE Sleep and Human Health Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
2. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
3. New Study Shares Benchmarks for Fixed-Dose Combination (FDC) Drug Development
4. New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
5. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
6. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
7. New Study Provides Benchmarks for Winning Brand Team Management
8. New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
9. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
10. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
11. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):